X @Bloomberg
Bloomberg·2025-12-19 13:07
BioMarin Pharmaceutical Inc. agreed to buy Amicus Therapeutics Inc. for about $4.8 billion to expand its portfolio of treatments for rare diseases. https://t.co/ChUMv6l4pJ ...
BioMarin Pharmaceutical Inc. agreed to buy Amicus Therapeutics Inc. for about $4.8 billion to expand its portfolio of treatments for rare diseases. https://t.co/ChUMv6l4pJ ...